Amitryptyline
Amitryptyline market is segmented by region (country), players, by Type and by Application. Playe ... Read More
Global and United States Dalfampridine Market Report & Forecast 2023-2028
1 Study Coverage
1.1 Dalfampridine Product Introduction
1.2 Global Dalfampridine Outlook 2017 VS 2022 VS 2028
1.2.1 Global Dalfampridine Sales in US$ Million for the Year 2017-2028
1.2.2 Global Dalfampridine Sales in Volume for the Year 2017-2028
1.3 United States Dalfampridine Outlook 2017 VS 2022 VS 2028
1.3.1 United States Dalfampridine Sales in US$ Million for the Year 2017-2028
1.3.2 United States Dalfampridine Sales in Volume for the Year 2017-2028
1.4 Dalfampridine Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Dalfampridine in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Dalfampridine Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Dalfampridine Market Dynamics
1.5.1 Dalfampridine Industry Trends
1.5.2 Dalfampridine Market Drivers
1.5.3 Dalfampridine Market Challenges
1.5.4 Dalfampridine Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Dalfampridine Market Segment by Type
2.1.1 10 mg
2.1.2 Others
2.2 Global Dalfampridine Market Size by Type
2.2.1 Global Dalfampridine Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Dalfampridine Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Dalfampridine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Dalfampridine Market Size by Type
2.3.1 United States Dalfampridine Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Dalfampridine Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Dalfampridine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Dalfampridine Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Dalfampridine Market Size by Application
3.2.1 Global Dalfampridine Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Dalfampridine Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Dalfampridine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Dalfampridine Market Size by Application
3.3.1 United States Dalfampridine Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Dalfampridine Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Dalfampridine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Dalfampridine Competitor Landscape by Company
4.1 Global Dalfampridine Market Size by Company
4.1.1 Top Global Dalfampridine Manufacturers Ranked by Revenue (2021)
4.1.2 Global Dalfampridine Revenue by Manufacturer (2017-2022)
4.1.3 Global Dalfampridine Sales by Manufacturer (2017-2022)
4.1.4 Global Dalfampridine Price by Manufacturer (2017-2022)
4.2 Global Dalfampridine Concentration Ratio (CR)
4.2.1 Dalfampridine Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Dalfampridine in 2021
4.2.3 Global Dalfampridine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Dalfampridine Manufacturing Base Distribution, Product Type
4.3.1 Global Dalfampridine Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Dalfampridine Product Type
4.3.3 Date of International Manufacturers Enter into Dalfampridine Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Dalfampridine Market Size by Company
4.5.1 Top Dalfampridine Players in United States, Ranked by Revenue (2021)
4.5.2 United States Dalfampridine Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Dalfampridine Sales by Players (2020, 2021 & 2022)
5 Global Dalfampridine Market Size by Region
5.1 Global Dalfampridine Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Dalfampridine Market Size in Volume by Region (2017-2028)
5.2.1 Global Dalfampridine Sales in Volume by Region: 2017-2022
5.2.2 Global Dalfampridine Sales in Volume Forecast by Region (2023-2028)
5.3 Global Dalfampridine Market Size in Value by Region (2017-2028)
5.3.1 Global Dalfampridine Sales in Value by Region: 2017-2022
5.3.2 Global Dalfampridine Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Dalfampridine Market Size YoY Growth 2017-2028
6.1.2 North America Dalfampridine Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Dalfampridine Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Dalfampridine Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Dalfampridine Market Size YoY Growth 2017-2028
6.3.2 Europe Dalfampridine Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Dalfampridine Market Size YoY Growth 2017-2028
6.4.2 Latin America Dalfampridine Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Dalfampridine Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Dalfampridine Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Acorda Therapeutics
7.1.1 Acorda Therapeutics Corporation Information
7.1.2 Acorda Therapeutics Description and Business Overview
7.1.3 Acorda Therapeutics Dalfampridine Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Acorda Therapeutics Dalfampridine Products Offered
7.1.5 Acorda Therapeutics Recent Development
7.2 Elan Pharma
7.2.1 Elan Pharma Corporation Information
7.2.2 Elan Pharma Description and Business Overview
7.2.3 Elan Pharma Dalfampridine Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Elan Pharma Dalfampridine Products Offered
7.2.5 Elan Pharma Recent Development
7.3 Biogen
7.3.1 Biogen Corporation Information
7.3.2 Biogen Description and Business Overview
7.3.3 Biogen Dalfampridine Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Biogen Dalfampridine Products Offered
7.3.5 Biogen Recent Development
7.4 Sun Pharmaceutical
7.4.1 Sun Pharmaceutical Corporation Information
7.4.2 Sun Pharmaceutical Description and Business Overview
7.4.3 Sun Pharmaceutical Dalfampridine Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Sun Pharmaceutical Dalfampridine Products Offered
7.4.5 Sun Pharmaceutical Recent Development
7.5 Aurobindo Pharma
7.5.1 Aurobindo Pharma Corporation Information
7.5.2 Aurobindo Pharma Description and Business Overview
7.5.3 Aurobindo Pharma Dalfampridine Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Aurobindo Pharma Dalfampridine Products Offered
7.5.5 Aurobindo Pharma Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Dalfampridine Industry Chain Analysis
8.2 Dalfampridine Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Dalfampridine Distributors
8.3 Dalfampridine Production Mode & Process
8.4 Dalfampridine Sales and Marketing
8.4.1 Dalfampridine Sales Channels
8.4.2 Dalfampridine Distributors
8.5 Dalfampridine Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Dalfampridine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Dalfampridine Market Trends
Table 3. Dalfampridine Market Drivers
Table 4. Dalfampridine Market Challenges
Table 5. Dalfampridine Market Restraints
Table 6. Global Dalfampridine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Dalfampridine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Dalfampridine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Dalfampridine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Dalfampridine Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Dalfampridine Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Dalfampridine Revenue Share by Manufacturer, 2017-2022
Table 13. Global Dalfampridine Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Dalfampridine Sales Share by Manufacturer, 2017-2022
Table 15. Global Dalfampridine Price by Manufacturer (2017-2022) & (US$/Unit)
Table 16. Global Dalfampridine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Dalfampridine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dalfampridine as of 2021)
Table 18. Top Players of Dalfampridine in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Dalfampridine Product Type
Table 20. Date of International Manufacturers Enter into Dalfampridine Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Dalfampridine Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Dalfampridine Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Dalfampridine Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Dalfampridine Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Dalfampridine Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Dalfampridine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Dalfampridine Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Dalfampridine Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Dalfampridine Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Dalfampridine Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Dalfampridine Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Dalfampridine Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Dalfampridine Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Dalfampridine Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Dalfampridine Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Dalfampridine Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Dalfampridine Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Dalfampridine Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Dalfampridine Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Dalfampridine Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Acorda Therapeutics Corporation Information
Table 43. Acorda Therapeutics Description and Business Overview
Table 44. Acorda Therapeutics Dalfampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 45. Acorda Therapeutics Dalfampridine Product
Table 46. Acorda Therapeutics Recent Development
Table 47. Elan Pharma Corporation Information
Table 48. Elan Pharma Description and Business Overview
Table 49. Elan Pharma Dalfampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 50. Elan Pharma Product
Table 51. Elan Pharma Recent Development
Table 52. Biogen Corporation Information
Table 53. Biogen Description and Business Overview
Table 54. Biogen Dalfampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 55. Biogen Product
Table 56. Biogen Recent Development
Table 57. Sun Pharmaceutical Corporation Information
Table 58. Sun Pharmaceutical Description and Business Overview
Table 59. Sun Pharmaceutical Dalfampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 60. Sun Pharmaceutical Product
Table 61. Sun Pharmaceutical Recent Development
Table 62. Aurobindo Pharma Corporation Information
Table 63. Aurobindo Pharma Description and Business Overview
Table 64. Aurobindo Pharma Dalfampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 65. Aurobindo Pharma Product
Table 66. Aurobindo Pharma Recent Development
Table 67. Key Raw Materials Lists
Table 68. Raw Materials Key Suppliers Lists
Table 69. Dalfampridine Customers List
Table 70. Dalfampridine Distributors List
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Dalfampridine Product Picture
Figure 2. Global Dalfampridine Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Dalfampridine Market Size 2017-2028 (US$ Million)
Figure 4. Global Dalfampridine Sales 2017-2028 (K Units)
Figure 5. United States Dalfampridine Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Dalfampridine Market Size 2017-2028 (US$ Million)
Figure 7. United States Dalfampridine Sales 2017-2028 (K Units)
Figure 8. United States Dalfampridine Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Dalfampridine Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Dalfampridine Report Years Considered
Figure 11. Product Picture of 10 mg
Figure 12. Product Picture of Others
Figure 13. Global Dalfampridine Market Share by Type in 2022 & 2028
Figure 14. Global Dalfampridine Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Dalfampridine Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Dalfampridine Sales by Type (2017-2028) & (K Units)
Figure 17. Global Dalfampridine Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Dalfampridine Price by Type (2017-2028) & (US$/Unit)
Figure 19. United States Dalfampridine Market Share by Type in 2022 & 2028
Figure 20. United States Dalfampridine Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Dalfampridine Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Dalfampridine Sales by Type (2017-2028) & (K Units)
Figure 23. United States Dalfampridine Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Dalfampridine Price by Type (2017-2028) & (US$/Unit)
Figure 25. Product Picture of Hospitals
Figure 26. Product Picture of Clinics
Figure 27. Product Picture of Others
Figure 28. Global Dalfampridine Market Share by Application in 2022 & 2028
Figure 29. Global Dalfampridine Sales in Value by Application (2017-2028) & (US$ Million)
Figure 30. Global Dalfampridine Sales Market Share in Value by Application (2017-2028)
Figure 31. Global Dalfampridine Sales by Application (2017-2028) & (K Units)
Figure 32. Global Dalfampridine Sales Market Share in Volume by Application (2017-2028)
Figure 33. Global Dalfampridine Price by Application (2017-2028) & (US$/Unit)
Figure 34. United States Dalfampridine Market Share by Application in 2022 & 2028
Figure 35. United States Dalfampridine Sales in Value by Application (2017-2028) & (US$ Million)
Figure 36. United States Dalfampridine Sales Market Share in Value by Application (2017-2028)
Figure 37. United States Dalfampridine Sales by Application (2017-2028) & (K Units)
Figure 38. United States Dalfampridine Sales Market Share in Volume by Application (2017-2028)
Figure 39. United States Dalfampridine Price by Application (2017-2028) & (US$/Unit)
Figure 40. North America Dalfampridine Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 41. North America Dalfampridine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 42. U.S. Dalfampridine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Canada Dalfampridine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Europe Dalfampridine Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 45. Europe Dalfampridine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. Germany Dalfampridine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. France Dalfampridine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. U.K. Dalfampridine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Italy Dalfampridine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Russia Dalfampridine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Asia-Pacific Dalfampridine Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 52. Asia-Pacific Dalfampridine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. China Dalfampridine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Japan Dalfampridine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. South Korea Dalfampridine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. India Dalfampridine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Australia Dalfampridine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Taiwan Dalfampridine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Indonesia Dalfampridine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Thailand Dalfampridine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Malaysia Dalfampridine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Philippines Dalfampridine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Latin America Dalfampridine Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 64. Latin America Dalfampridine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 65. Mexico Dalfampridine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Brazil Dalfampridine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Argentina Dalfampridine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Middle East & Africa Dalfampridine Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 69. Middle East & Africa Dalfampridine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Turkey Dalfampridine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Saudi Arabia Dalfampridine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. UAE Dalfampridine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Dalfampridine Value Chain
Figure 74. Dalfampridine Production Process
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Acorda Therapeutics Elan Pharma Biogen Sun Pharmaceutical Aurobindo Pharma